# Elephas Biosciences Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/elephas-biosciences

- Industry: Biotechnology
- Headquarters: Madison, US
- Website: www.elephas.com
- Total disclosed funding: $153M
- Latest round: Series B (Nov 6, 2025)
- Investors on record: 8

## About

Based in Wisconsin, US, and founded in 2020 by its CEO Maneesh Arora, Elephas Biosciences Corporation operates as a developer and provider of biotechnology imaging platforms to help in diagnostics and novel pharmaceutical therapies. In November 2025, Elephas Biosciences Corp raised USD 40 million in series B funding from Northpond Ventures, ARCH Venture Partners, State of Wisconsin Investment Board, Tao Capital Partners, Sands Capital Alternatives, and Venture Investors.

Elephas Biosciences Corp. offers an oncology diagnostics platform that utilizes live fragments from a patient biopsy and treats those fragments with potential therapies and combinations. The company's CybridTM platform incorporates a comprehensive suite of assays to help understand the mechanisms of action of immunotherapeutic compounds indicating drug response, and it also provides insights into cancer treatment decisions and accelerates immuno-oncology drug development.

The organization plans to use the November 2025 funding to launch and commercialize its Elephas Live platform as a laboratory-developed test that predicts immunotherapy response using live tumor biopsies.

## Funding rounds

- Series B, Nov 6, 2025, $40M — ARCH Venture Partners, Venture Investors, State of Wisconsin Investment Board, Tao Capital Partners, Sands Capital Alternatives, Northpond Ventures
- Series C, Nov 30, 2023, $51M — ARCH Venture Partners, Venture Investors, State of Wisconsin Investment Board, Tao Capital Partners, Sands Capital Alternatives, Northpond Ventures, Moore Strategic Ventures, WARF Ventures
- Series B, Sep 6, 2022, $42M — ARCH Venture Partners, Tao Capital Partners, Sands Capital Alternatives, Northpond Ventures, Moore Strategic Ventures, WARF Ventures
- Series A, Sep 15, 2021, $20M — Sands Capital Alternatives, Northpond Ventures, WARF Ventures

## Investors

- Sands Capital Alternatives (https://capitalatlas.ai/funds/sands-capital-alternatives) — Series A, Series B, Series C
- Northpond Ventures (https://capitalatlas.ai/funds/northpond-ventures) — Series A, Series B, Series C
- WARF Ventures (https://capitalatlas.ai/funds/warf-ventures) — Series A, Series B, Series C
- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series B, Series C
- Tao Capital Partners (https://capitalatlas.ai/funds/tao-capital-partners) — Series B, Series C
- Moore Strategic Ventures (https://capitalatlas.ai/funds/moore-strategic-ventures) — Series B, Series C
- Venture Investors — Series C, Series B
- State of Wisconsin Investment Board — Series C, Series B